Pharmacokinetics of (S)-9-[2-(phosophonylmethoxy) ethyl]adenine (PMEA) and zidovudine (AZT) when administered in combination

Journal of Applied Therapeutics

Volumn 1, Issue 1, 1996, Pages 13-18

  Lush, R M ^a   Nguyen, B Y ^a   Cundy, K C ^a   Bauza, S ^a   Sogocio, T ^a   Stevens, J ^a   Piscitelli, S C ^a   Venzon, D J ^a   Yarchoan, R ^a   Figg, W D ^a  

^a Clinical Pharmacology Branch   (United States)

Author keywords

9 (2 phosophonylmethoxyethyl) adenine; AZT; HIV; Pharmacokinetics; PMEA; Zidovudine

Indexed keywords

ADEFOVIR; ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG HALF LIFE; DRUG METABOLISM; DRUG MIXTURE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY CLEARANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT PLANNING; URINARY EXCRETION;

EID: 0030318236     PISSN: 10721754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)